Home > Products > CD28 & CD3 > Recombinant Anti-CD28 x Anti-CD3 Bispecific Antibody (sdAb-Fc-sdAb)

Recombinant Anti-CD28 x Anti-CD3 Bispecific Antibody (sdAb-Fc-sdAb)  (CAT#: HCAB-011)

Recombinant Anti-CD28 x Anti-CD3 Bispecific Antibody (sdAb-Fc-sdAb, Tetravalent Heavy Chain-only Antibody, Tetravalent HCAb) is symmetric protein with two pairs of single domain antibodies (sdAb), from anti-CD28 and anti-CD3 antibodies, fused to the N-terminus and C-terminus of the Fc separately. This BsAb is bispecific, tetravelant, 2+2 antigen-binding valency. It can improve T-cell activation. It is designed for the research of Tumors therapy.
Datasheet INQUIRY

Specifications

Targets
CD28 & CD3
Type
sdAb-Fc-sdAb
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Tumors
Host Animal 1
llama
Host Animal 2
llama

Targets

Target 1
CD28
Gene ID
UniProt ID
Alternative Names
CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen
Target 2
CD3
Gene ID
UniProt ID
Alternative Names
EGFR; epidermal growth factor receptor; ERBB; HER1; mENA; ERBB1; PIG61; NISBD2; proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; erb-b2 receptor tyrosine kinase 1; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase erbB-1; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD28 & CD3"
See other bsAb targets related to "CD3"

See other bsAb targets related to "CD28"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-CD3 Bispecific Antibody (sdAb-Fc-sdAb) (HCAB-011). Click the button below to contact us or submit your feedback about this product.